NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 29, 2024 $5.62 -2.43% $5.74 V 97.91% 1
Oct 29, 2024 $5.67 -1.52% $5.74 V 98.83% 2
Oct 29, 2024 Bullish $5.74 X 0
Apr 22, 2024 $8.56 +4.78% $8.09 X 94.18% 0
Apr 22, 2024 $8.41 +2.99% $8.09 X 95.99% 0
Apr 22, 2024 Bullish $8.09 X 0
JS JS Pro
Jun 28, 2023 $1.68 -94.91% $1.67 X 99.10% 2
Jun 28, 2023 $1.70 -94.84% $1.67 X 97.73% 1
Jun 28, 2023 $1.68 -94.90% $1.67 X 98.92% 2
Jun 8, 2023 Bearish $1.74 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE